NCT07290712 Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region
| NCT ID | NCT07290712 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Vienna |
| Condition | PICS |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2026-02-04 |
| Primary Completion | 2030-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2026-02-04 with a primary completion date of 2030-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Post-Intensive Care Syndrome (PICS) refers to long-term cognitive, physical, and psychological impairments that can arise after intensive care treatment. These symptoms may begin within 24 hours of ICU admission and persist for years. Affected patients and their families (PICS-F) face significant burdens, with up to 94% of relatives impacted. Given its high prevalence and socioeconomic impact, this prospective registry study aims to identify risk factors and long-term consequences of PICS and PICS-F. The study consists of six modules, starting with data collection during ICU stays and continuing with follow-ups at various intervals post-discharge (up to five years). The primary goal is to investigate diagnostic and therapeutic strategies, while secondary objectives include identifying risk factors, determining impairment severity, and exploring biological mechanisms. Standardized questionnaires and biological samples (blood) are used for data collection.
Eligibility Criteria
Inclusion Criteria: * Patients with an ICU stay longer than 72 hours will be included Exclusion Criteria: * Age \< 18 years old * Patients who receive end-of-life care at the time of screening
Contact & Investigator
Stefan J Schaller, MD
PRINCIPAL INVESTIGATOR
Medical University of Vieanna
Frequently Asked Questions
Who can join the NCT07290712 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying PICS. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07290712 currently recruiting?
Yes, NCT07290712 is actively recruiting participants. Contact the research team at pics-dach-sc@listserv.muv.ac.at for enrollment information.
Where is the NCT07290712 trial being conducted?
This trial is being conducted at Vienna, Austria, Augsburg, Germany, Würzburg, Germany, Berlin, Germany.
Who is sponsoring the NCT07290712 clinical trial?
NCT07290712 is sponsored by Medical University of Vienna. The principal investigator is Stefan J Schaller, MD at Medical University of Vieanna. The trial plans to enroll 5,000 participants.